We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+26.43%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.88B
AUM Growth
+$195M
Cap. Flow
-$176M
Cap. Flow %
-9.38%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$9.78M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$125M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$69.8M

Sector Composition

Rank Sector Weight
1 Healthcare 62.62%
2 Consumer Staples 22.55%
3 Industrials 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$1.01B 53.49%
9,544,091
-1,251,257
-12% -$125M
MNST icon
2
Monster Beverage
MNST
$94.3B
$424M 22.55%
9,312,976
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$152M 8.1%
690,000
-319,700
-32% -$69.8M
AXON
4
Axon Enterprise
AXON
$42.5B
$108M 5.75%
760,062
– –
IMDX
5
Insight Molecular Diagnostics
IMDX
$150M
$87.1M 4.63%
838,824
+103,014
+14% +$9.78M
LCTX icon
6
Lineage Cell Therapeutics
LCTX
$269M
$79.9M 4.25%
34,005,379
– –
MNST icon
7
PUT
Monster Beverage
MNST
$94.3B
$18.2M 0.97%
400,000
+200,000
+100% +$8.96M
SER icon
8
Serina Therapeutics
SER
$30M
$4.86M 0.26%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Broadwood Capital held 8 positions worth $1.88B, up 12% from $1.69B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $176M in Q1 2021, reducing 2 holdings. Its largest reduction was STAAR Surgical, cutting an estimated $125M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 57% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Broadwood Capital added an estimated $9.78M to Insight Molecular Diagnostics.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q1 2021, an estimated $9.78M increase.
  • Broadwood Capital's biggest Q1 2021 reduction was STAAR Surgical, cutting an estimated $125M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.88B portfolio in Q1 2021.
  • Broadwood Capital opened 0 new positions and closed 0 in Q1 2021.
  • Broadwood Capital's portfolio value rose 12% quarter-over-quarter to $1.88B.

Based on Broadwood Capital's 13F filing for Q1 2021, filed 17 May 2021.